Picture of Aptamer logo

APTA Aptamer Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-11.92%
3m-55.35%
6m-57.56%
1yr-97.84%
Volume Change (%)
10d/3m-60.07%
Price vs... (%)
52w High-98.2%
50d MA-13.77%
200d MA-59.98%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-266.19%
Return on Equity-187.54%
Operating Margin-687.73%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202430th Jun 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Aptamer EPS forecast chart

Profile Summary

Aptamer Group plc is a developer of Optimer binders in the life sciences industry. It offers custom Optimer selection and development services. It delivers aptamer-based solutions to its customer bases for a range of therapeutic, diagnostic, and target-binding applications. It develops Optimer binders for therapeutics, diagnostics, bioprocessing, and research applications. The Optimer platform delivers aptamer tools that enables researchers and developers across the spectrum of the life sciences. Optimer binders has developed for a range of applications, including therapeutic inhibitors and modulators, drug delivery vehicles, protein purification and separation, biomarker screening and validation, in vitro research, quality control analysis, pharmacokinetic and drug assays, and in vitro diagnostic assays. Optimer act as agonists, antagonists, or cell-type-specific targeting moieties for the delivery of therapeutic agents to target cells and tissues in the treatment of disease.

Directors

    Last Annual
    June 30th, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    May 29th, 2014
    Public Since
    December 22nd, 2021
    No. of Employees
    54
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    467,343,673

    APTA Share Price Performance

    Similar to APTA

    Picture of Abingdon Health logo

    Abingdon Health

    gb flag iconLondon Stock Exchange

    Picture of Advanced Medical Solutions logo

    Advanced Medical Solutions

    gb flag iconLondon Stock Exchange

    Picture of Advanced Oncotherapy logo

    Advanced Oncotherapy

    gb flag iconLondon Stock Exchange

    Picture of Angle logo

    Angle

    gb flag iconLondon Stock Exchange

    Picture of Belluscura logo

    Belluscura

    gb flag iconLondon Stock Exchange

    FAQ